Todos Medical Ltd. (TOMDF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2022 | -9.74 Million USD | -4.98% |
| 2021 | -9.28 Million USD | 34.89% |
| 2020 | -14.26 Million USD | -305.69% |
| 2019 | -3.51 Million USD | -154.93% |
| 2018 | -1.37 Million USD | -3.08% |
| 2017 | -1.33 Million USD | -83.51% |
| 2016 | -728.88 Thousand USD | 12.29% |
| 2015 | -830.98 Thousand USD | -107.31% |
| 2014 | -400.84 Thousand USD | -18.06% |
| 2013 | -339.53 Thousand USD | -138771.71% |
| 2012 | -244.49 USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q3 | - USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2023 Q1 | - USD | 100.0% |
| 2022 Q4 | -2.04 Million USD | -18.04% |
| 2022 Q2 | -1.83 Million USD | 45.85% |
| 2022 FY | -9.74 Million USD | -4.98% |
| 2022 Q1 | -3.38 Million USD | 6.04% |
| 2022 Q3 | -1.73 Million USD | 5.22% |
| 2021 Q1 | -1.83 Million USD | -65.2% |
| 2021 FY | -9.28 Million USD | 34.89% |
| 2021 Q4 | -3.59 Million USD | -44.09% |
| 2021 Q3 | -2.49 Million USD | -50.24% |
| 2021 Q2 | -1.66 Million USD | 9.53% |
| 2020 Q1 | -1.18 Million USD | 0.0% |
| 2020 FY | -14.26 Million USD | -305.69% |
| 2020 Q4 | -1.11 Million USD | 89.15% |
| 2020 Q3 | -10.24 Million USD | -496.04% |
| 2020 Q2 | -1.71 Million USD | -45.19% |
| 2019 FY | -3.51 Million USD | -154.93% |
| 2018 FY | -1.37 Million USD | -3.08% |
| 2017 FY | -1.33 Million USD | -83.51% |
| 2016 FY | -728.88 Thousand USD | 12.29% |
| 2015 Q4 | -147.22 Thousand USD | 0.0% |
| 2015 Q3 | -147.22 Thousand USD | 45.12% |
| 2015 Q2 | -268.26 Thousand USD | 0.0% |
| 2015 Q1 | -268.26 Thousand USD | -160.77% |
| 2015 FY | -830.98 Thousand USD | -107.31% |
| 2014 Q1 | -97.55 Thousand USD | 0.0% |
| 2014 Q4 | -102.87 Thousand USD | -0.0% |
| 2014 Q2 | -97.54 Thousand USD | 0.0% |
| 2014 FY | -400.84 Thousand USD | -18.06% |
| 2014 Q3 | -102.87 Thousand USD | -5.46% |
| 2013 FY | -339.53 Thousand USD | -138771.71% |
| 2012 FY | -244.49 USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.24 Million USD | -684.863% |
| Arrayit Corporation | -3.62 Million USD | -169.095% |
| Atlantic International Corp. | -5.73 Million USD | -70.048% |
| Biocept, Inc. | -31.98 Million USD | 69.521% |
| Bioqual, Inc. | -19.63 Thousand USD | -49538.456% |
| CardioGenics Holdings Inc | -772.14 Thousand USD | -1162.462% |
| DermTech, Inc. | -103.73 Million USD | 90.603% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.48 Billion USD | 100.392% |
| HTG Molecular Diagnostics, Inc. | -20.82 Million USD | 53.201% |
| iMD Companies, Inc. | -175.44 Thousand USD | -5456.126% |
| IDenta Corp. | -1499.00 USD | -650200.2% |
| Interpace Biosciences, Inc. | 2.8 Million USD | 447.646% |
| Integrative Health Technologies, Inc. | 38.69 Thousand USD | 25295.141% |
| InVitro International | -25.33 Thousand USD | -38370.342% |
| Lumos Diagnostics Holdings Limited | -7.12 Million USD | -36.872% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | -16674.504% |
| Medical Imaging Corp. | -819.48 Thousand USD | -1089.535% |
| NovelStem International Corp. | -3.52 Million USD | -176.476% |
| Optigenex Inc. | 1.39 Million USD | 800.874% |
| PharmChem, Inc. | 973.14 Thousand USD | 1101.699% |
| Proteome Sciences plc | -1.62 Million USD | -501.357% |
| Response Genetics, Inc | -21.37 Million USD | 54.4% |
| Rennova Health, Inc. | -1.4 Million USD | -591.576% |
| RushNet, Inc. | -684.7 Thousand USD | -1323.679% |
| ScreenPro Security Inc. | -2.59 Million USD | -276.018% |
| Stella Diagnostics Inc. | -11.42 Million USD | 14.693% |
| StageZero Life Sciences Ltd. | -7.74 Million USD | -25.833% |